Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-01 4:16 pm Purchase |
2024-06-27 | 13D | Connect Biopharma Holdings Limited CNTB |
Panacea Venture Healthcare Fund II, L.P. | 13,410,000 24.300% |
1,410,000 (+11.75%) |
Filing History |
| 2024-02-27 9:00 pm Purchase |
2024-02-23 | 13D | Connect Biopharma Holdings Limited CNTB |
Panacea Venture Healthcare Fund II, L.P. | 12,000,000 21.800% |
3,100,000 (+34.83%) |
Filing History |
| 2024-02-27 4:19 pm Sale |
2024-02-23 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 0 0.000% |
-3,062,871 (Position Closed) |
Filing History |
| 2024-02-13 4:30 pm Purchase |
2024-02-12 | 13D | Connect Biopharma Holdings Limited CNTB |
Panacea Venture Healthcare Fund II, L.P. | 8,900,000 16.200% |
8,900,000 (New Position) |
Filing History |
| 2024-02-13 4:27 pm Purchase |
2023-12-31 | 13G | Connect Biopharma Holdings Limited CNTB |
BioFortune Inc | 6,728,292 12.100% |
511,767 (+8.23%) |
Filing History |
| 2024-02-13 4:18 pm Purchase |
2023-12-31 | 13G | Connect Biopharma Holdings Limited CNTB |
Wei Zheng | 6,487,545 11.700% |
262,198 (+4.21%) |
Filing History |
| 2023-12-20 4:30 pm Sale |
2023-12-18 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 3,062,871 5.600% |
-2,061,438 (-40.23%) |
Filing History |
| 2023-12-14 4:30 pm Sale |
2023-12-12 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 5,124,309 9.300% |
-830,702 (-13.95%) |
Filing History |
| 2023-12-04 5:20 pm Sale |
2023-11-30 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 5,955,011 10.800% |
-1,035,992 (-14.82%) |
Filing History |
| 2023-10-04 5:26 pm Purchase |
2023-10-02 | 13G | Connect Biopharma Holdings Limited CNTB |
Huang James | 5,995,000 10.900% |
3,175,000 (+112.59%) |
Filing History |
| 2023-02-14 06:27 am Purchase |
2022-12-31 | 13G | Connect Biopharma Holdings Limited CNTB |
Qiming Corporate GP V, Ltd. | 3,198,755 5.800% |
3,198,755 (New Position) |
Filing History |
| 2023-02-13 5:20 pm Purchase |
2022-12-31 | 13G | Connect Biopharma Holdings Limited CNTB |
Shanghai Minhui Enterprise Management Consulting Partnership (Limited Partnership) | 5,306,149 9.600% |
5,306,149 (New Position) |
Filing History |
| 2023-02-13 5:13 pm Purchase |
2022-12-31 | 13G | Connect Biopharma Holdings Limited CNTB |
Wei Zheng | 6,225,347 11.300% |
174,103 (+2.88%) |
Filing History |
| 2023-02-13 5:13 pm Purchase |
2022-12-31 | 13G | Connect Biopharma Holdings Limited CNTB |
BioFortune Inc | 6,216,525 11.300% |
100,134 (+1.64%) |
Filing History |
| 2023-02-09 09:59 am Sale |
2023-02-09 | 13G | Connect Biopharma Holdings Limited CNTB |
FMR CORP | 82 0.000% |
-3,417,482 (-100.00%) |
Filing History |
| 2023-01-03 4:31 pm Purchase |
2022-12-22 | 13G | Connect Biopharma Holdings Limited CNTB |
Huang James | 2,820,000 5.100% |
2,820,000 (New Position) |
Filing History |
| 2022-02-25 4:43 pm Purchase |
2021-12-31 | 13G | Connect Biopharma Holdings Limited CNTB |
Wei Zheng | 6,051,244 11.000% |
6,051,244 (New Position) |
Filing History |
| 2022-02-25 4:42 pm Purchase |
2021-12-31 | 13G | Connect Biopharma Holdings Limited CNTB |
BioFortune Inc | 6,116,391 11.100% |
6,116,391 (New Position) |
Filing History |
| 2022-02-15 06:05 am Purchase |
2021-12-31 | 13G | Connect Biopharma Holdings Limited CNTB |
Advantech Capital II L.P. | 4,762,185 8.500% |
4,762,185 (New Position) |
Filing History |
| 2022-02-14 06:13 am Purchase |
2021-12-31 | 13G | Connect Biopharma Holdings Limited CNTB |
Qiming Venture Partners VII L.P. | 3,198,755 5.800% |
3,198,755 (New Position) |
Filing History |